OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
May 23, 2024
The latest news for pharma industry insiders.
May 22, 2024
The document reiterates the company’s commitment to ESG principles, including carbon neutrality by 2030.
The decision comes after success during formulation testing with convincing stability data.
May 21, 2024
The agreement is expected to focus on cell manufacturing processes, with potential for sharing tech with academia, startups.
In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the pharma industry.
May 20, 2024
The facility, company says, will be its first that covers end-to-end ADC production.
The company increases its selection of atopic dermatitis treatments in the process.